|
| Effect of GAPT Extract on Expression of Tau Protein and Its Phosphorylation Related Enzymes in Hippocampal Neurons of APPV717I Transgenic Mice |
| |
| View Full Text View/Add Comment Download reader |
|
| KeyWord:Alzheimer's disease, tau, APPV717I transgenic mice, Chinese medicine |
|
| Hits: 892 |
| Download times: 0 |
| Abstract: |
| Objective: To investigate the effect of GAPT, an extract mixture from Radix Ginseng, Rhizoma Acor tatarinowii, Radix Polygalae and Radix Curcuma (containing ingredient of turmeric), etc. on expression of tau protein and its phosphorylation related enzyme in hippocampal neurons of APPV717I transgenic mice. Methods: Sixty three-month-old APPV717I transgenic mice were randomly divided into model group, donepezil group [0.92 mg/(kg?d)], the low, medium and high dosage of GAPT groups [0.075, 0.15, 0.30 g/(kg?d), 12 in each group], and 12 three-month-old C57BL/6J mice were set as a normal control group, treatments were administered orally once a day respectively, and both the normal group and model group were given 0.5% sodium carboxymethyl cellulose solution. Immunohistochemistry (IHC) and Western blot analysis were used to detect the expression of total tau protein (Tau-5), cyclin-dependent kinase 5 (CDK5) and protein phosphatase 2A (PP2A) in hippocampal neurons of experimental mice after 8-month drug administration (11 months old). Results: In the model group, the expression of Tau-5 and CDK5 were increased, whereas the expression of PP2A was decreased in hippocampal neurons, which were significantly different compared with that in the normal group (all P<0.01). IHC test indicated the number and area of either Tau-5 or CDK5 positive cells were decreased with a dose-depended way in GAPT groups, and an increase of PP2A. Compared with the model group, the changes were significant in GAPT groups (P<0.05 or P<0.01). Similar results were shown by Western blot. Conclusion: GAPT could attenuate abnormal hyperphosphorylation of tau protein in hippocampal neurons of APPV717I transgenic mice via inhibiting the expression of CDK5 and activating the expression of PP2A. |
| Close |
|
|
|
